As indications and opportunities for liver transplant evolve, transplant experts encourage gastroenterologists not to hesitate to refer their patients and refer earlier.
Endohepatology offers safety and accuracy that matches gold standard approaches for liver disease diagnosis and management and the patient advantage of “one-stop shopping,” says Dr. Jerome Edelson.
Guidelines provide comprehensive guidance on what’s different and essential in treating children and youth with MASLD.
Methylation patterns in DNA at birth are associated with risk factors for metabolic disorders later in life and could serve as predictive biomarkers for liver disease, says Dr. Ashley Jowell.
The proposal focuses on establishing point-of-care testing, increasing medication access among underserved populations, and engaging community organizations to drive awareness and increase screening.
A retrospective cohort study shows that GLP-1 agonists reduced the risk of cirrhosis and HCC in patients with MASLD and Type 2 diabetes.
New AASLD guidelines broadly recommend simple, cost-effective blood-based tests and elastography for many patients with chronic liver disease.
Simple blood-based tests can be used to identify which patients with MASLD should receive liver-directed therapy, but hepatologists may need more accurate measures, says Dr. Veeral Ajmera.
The Liver Meeting had ended, but your next opportunity to continue your hepatology education isn’t too far away.
Promoting gut health may improve outcomes in patients with cirrhosis, according to Dr. Jasmohan Bajaj.